SUSVIMO implant
May 23, 2025

FDA Approves Roche’s Susvimo for Diabetic Retinopathy

Genentech/Roche’s sustained release anti-VEGF eye implant provides a treatment option with reduced frequency for diabetic retinopathy. Sustained release anti-VEGF is…

Viridian_long term_durability_data_TED_2_copy
May 22, 2025

Viridian Shares New 52-Week Phase III Trial Data for Active TED

New THRIVE trial data highlight long-term proptosis response with veligrotug in thyroid eye disease patients. Fresh long-term data is showing…

popular posts
Thiết kế chưa có tên (15)
May 13, 2025

Aflibercept 8mg Has Been Available for Over a Year. Here’s What nAMD Experts Are Saying About Early Experiences. 

Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

Article 2 Day 5_ ARVO
May 9, 2025

The Next-Gen Arsenal of Genomic Tools for IRDs and Other Eye Diseases Lighting Up ARVO 2025

Article 2 Day 4_ARVO
May 8, 2025

Beyond the Genetic Code at ARVO 2025: Breakthrough Approaches to Retinal Repair

latest posts
ophthalmologist
September 14, 2020

OIS Retina Innovation Showcase: Panel of Experts Weigh-in on Pressing Retina Issues

Vector eyes collection, colored eye set
September 11, 2020

All Eyes on the Retina Innovation Showcase

syringe 3908153_1280
September 9, 2020

Researchers Announce Anti-VEGF Treatment Guidelines for Coronavirus Era

Myodesopsia (Eye Floaters) looking at the Sky
September 2, 2020

Floaters and YAG: Testing the Waters

Timing Is Everything Clock Concept
August 28, 2020

Treat-and-Extend Maintains Vision Gains Long-term in Clinical Trials and Real-world Practice

retinopathyimg
August 19, 2020

Exciting Developments in Retinopathy Treatment on the Horizon

Diabetes woman ready for morning run along the coast
August 3, 2020

Real World Results: Findings from the Protocol T Extension Study

heart 3147976_640
July 27, 2020

Farewell Sweet Summer Love: ASRS 2020 Day 3 LIVE Coverage

Discover our fascinating content at issuu

explore